Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/24 16:26 | 12/12/24 | TCRX | Health | BioPrd | Biological Products, (No Diag | Lynx1 Capital Management LP | PR | T | P.m | 386 | 2.93 | 0 | 132 | 1 | 10,615 | I | |||||||||||||||
11/19/24 16:26 | 11/15/24 | TCRX | Health | BioPrd | Biological Products, (No Diag | Lynx1 Capital Management LP | PR | T | P | 4 | 4.34 | 0 | 1 | 0 | 5,226 | I | |||||||||||||||
9/24/24 17:26 | 9/23/24 | TCRX | Health | BioPrd | Biological Products, (No Diag | Klencke Barbara | MA | D | P | 26 | 5.29 | 0 | 5 | 8 | 70 | D | |||||||||||||||
8/27/24 18:57 | 8/23/24 | TCRX | Health | BioPrd | Biological Products, (No Diag | Klencke Barbara | MA | D | P.m | 56 | 5.61 | 0 | 10 | 18 | 65 | D | |||||||||||||||
12/21/23 17:00 | 12/18/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Barberich Timothy J | MA | D | P.m | 142 | 4.89 | 0 | 29 | 41 | 100 | D | |||||||||||||||
12/18/23 18:01 | 12/14/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Klencke Barbara | MA | D | P | 25 | 5.08 | 0 | 5 | 10 | 55 | D | |||||||||||||||
6/6/23 19:53 | 6/2/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Barberich Timothy J | MA | D | P | 100 | 2.63 | 0 | 38 | 114 | 71 | D | |||||||||||||||
12/29/22 14:34 | 12/27/22 | TCRX | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P.m | 9 | 1.54 | 0 | 6 | 22 | 33 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |